This diagram outlines the dual potential of EV-RNAs in IBD: as non-invasive biomarkers for early diagnosis and monitoring, and as carriers of regulatory RNAs to target inflammation, repair the epithelial barrier, and restore gut homeostasis. (IMAGE)

ELSP

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.